TRIDENT LIFELINE
Back to Balance Sheet
|
TRIDENT LIFELINE Last 5 Year Total Liabilities History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|
| Total Liabilities | ₹155 Cr | ₹88 Cr | ₹62 Cr | ₹13 Cr |
What is the latest Total Liabilities ratio of TRIDENT LIFELINE ?
| Year | Total Liabilities |
|---|---|
| Mar2025 | ₹155 Cr |
| Mar2024 | ₹88 Cr |
| Mar2023 | ₹62 Cr |
| Mar2022 | ₹13 Cr |
How is Total Liabilities of TRIDENT LIFELINE Trending?
| Years | Total Liabilities | % Change | |
|---|---|---|---|
| Mar2025 | ₹155 Cr | 77.20 | |
| Mar2024 | ₹88 Cr | 40.45 | |
| Mar2023 | ₹62 Cr | 385.49 | |
| Mar2022 | ₹13 Cr | - | |
Compare Total Liabilities of peers of TRIDENT LIFELINE
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| TRIDENT LIFELINE | ₹363.0 Cr | 5.2% | 4.3% | -5.6% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹386,773.0 Cr | -6.8% | -7.6% | -4.7% | Stock Analytics | |
| DIVIS LABORATORIES | ₹159,540.0 Cr | -6.6% | -5.8% | 4.5% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹134,529.0 Cr | 0.9% | 5.7% | 27.3% | Stock Analytics | |
| CIPLA | ₹111,299.0 Cr | -4.8% | -8.1% | -3.9% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹97,393.0 Cr | -2% | -8.8% | -12.9% | Stock Analytics | |
TRIDENT LIFELINE Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| TRIDENT LIFELINE | 5.2% |
4.3% |
-5.6% |
| SENSEX | -2% |
-2.8% |
7.4% |
You may also like the below Video Courses